A Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular Dystrophy

Recruiting

GivinostatA Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular Dystrophy

Sponsor:

ITF Therapeutics LLC

Code:

NCT07127978

Conditions

Duchene Muscular Dystrophy

Eligibility Criteria

Sex: All

Age: 6+

Healthy Volunteers: Not accepted

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-10-18. This information was provided to ClinicalTrials.gov by ITF Therapeutics LLC on 2025-10-16.